Affimed Therapeutics B.V. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.54
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
6
|
|
# Buys
|
3
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.18
|
-0.11
|
0.07
|
38.89%
|
|
2022-06-30
|
-0.17
|
-0.13
|
0.04
|
23.53%
|
|
2022-03-31
|
-0.18
|
-0.14
|
0.04
|
22.22%
|
|
2021-12-31
|
-0.15
|
-0.19
|
-0.04
|
-26.67%
|
|
2021-09-30
|
-0.12
|
-0.14
|
-0.02
|
-16.67%
|
|
2021-06-30
|
-0.09
|
0.01
|
0.10
|
111.11%
|
|
2021-03-31
|
-0.04
|
-0.17
|
-0.13
|
-325.00%
|
|
2020-12-31
|
-0.05
|
-0.21
|
-0.16
|
-320.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.38
|
|
2021-12-31
|
-0.49
|
|
2020-12-31
|
-0.63
|
|
2019-12-31
|
-0.50
|
|
2018-12-31
|
-0.33
|
|
2017-12-31
|
-0.69
|
|
2016-12-31
|
-0.96
|
|
2015-12-31
|
-0.68
|
|
2014-12-31
|
2.06
|